Whether the problem be zoonoses, diseases that may be transmitted from animals to man, or animal diseases that become epidemics, preventive or therapeutic vaccines are a vital alternative. Therapeutic vaccines, developed by molecular biology, are a particularly novel way of treating diseases, and are based on using interfering RNA molecules. Towards the end of 2005, CIRAD developed and patented interfering RNAs that act against the morbilliviruses that cause measles, rinderpest and peste des petits ruminants. Since then, research work has continued with a view to targeting the effect of these biological antivirals in animals.
As Emmanuel Albina* explains, "Unlike chemical molecules, interfering RNA fragments that are only active on the target virus or family of viruses block the virus development process within infected cells." He adds "this strategy completely changes all the concepts of disease control. The choice is no longer limited to eradicating the infected animal population or mass preventive vaccination. A third tool, therapeutic vaccines, could be used on infected animals."
This new biological approach to animal diseases primarily applies to those affecting ruminants (rinderpest, peste des petits ruminants, foot and mouth, etc) and swine - pigs, wild boars - (African swine fever).
Man could also benefit from these new techniques. Measles, a human disease that affects young people in developing countries, belongs to the same virus family as peste des petits ruminants and rinderpest. Pharmaceutical research has also jumped on the bandwagon and is looking to use the same techniques to treat cancer.
* immunology and microbiology researcher with CIRAD
Helen Burford | alfa
New research recovers nutrients from seafood process water
31.10.2018 | Chalmers University of Technology
Plant Hormone Makes Space Farming a Possibility
17.10.2018 | Universität Zürich
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
19.11.2018 | Event News
09.11.2018 | Event News
06.11.2018 | Event News
19.11.2018 | Materials Sciences
19.11.2018 | Information Technology
19.11.2018 | Life Sciences